Idera Pharmaceuticals (IDRA)
2.31
-0.02 -0.86%
NASDAQ
Sep 20, 12:22
Delayed 2m
USD
View All Key Stats
IDRA Key Stats
| Income Statement | |
| Revenue (TTM) | 16.17M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.32 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -48.61M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -11.48K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 345.65M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 20.23 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 4.617 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0048 |
| Free Cash Flow (Quarterly) | -14.30M |
| Return on Equity (TTM) | -64.07% |
View All IDRA News
IDRA News
-
WireHeadlineTime (ET)
-
Yahoo09/19 17:46
-
Yahoo09/18 12:56
-
PR Newswire09/18 07:05
-
Yahoo09/12 08:47
-
Yahoo09/12 08:10
-
SA Breaking News09/11 12:48
-
MT Newswires09/11 12:44
-
Yahoo09/11 12:16
-
Yahoo09/11 09:46
-
SA Breaking News09/11 09:29
View All Events
IDRA Events
| Date | Type | Description |
|---|---|---|
| 06/07/2017 | Misc | Idera Pharmaceuticals Inc Annual General Meeting in 2016 |
| 05/04/2017 | Earnings | Idera Pharmaceuticals Inc First Quarter Earnings Results in 2017 |
| 03/15/2017 | Earnings | Idera Pharmaceuticals Inc Fourth Quarter Earnings Results in 2016 |
| 10/28/2016 | Earnings | Idera Pharmaceuticals Inc Third Quarter Earnings Results in 2016 |
IDRA Fundamentals
Income Statement View Statement
IDRA Ratings
Advertisement
IDRA One Page Reports
- One Page Report Download
IDRA Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 2.31 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.iderapharma.com
- Investor Relations URL: http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 04, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Idera Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in the discovery, development and commercialization of novel therapeutics for oncology and rare diseases.
IDRA Comparables
EditIDRA Excel Add-In Codes
- Name: =YCI("IDRA","name")
- Description: =YCI("IDRA","description")
- Sector: =YCI("IDRA","sector")
- Industry: =YCI("IDRA","industry")
- Est. Current Fiscal Year End: =YCI("IDRA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other IDRA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IDRA Tweets Stocktwits
Advertisement
